The following is an extract from their recent results release for thode interested.
HIGHLIGHTS:
• Revenue of $318 million – up 87% on PCP of $170 million
• Normalised EBITDA of $32.4 million – up 66% on PCP of $19.6 million
• Normalised NPAT of $17.3 million – up 70% on PCP of $10.2 million
• Normalised Cash inflow from Operations of $26.4 million up 105% on PCP of $12.9 million.
• Cash balance of $34.2 million and net cash of $18.7 million
• Earnings per share of 8.63 cents per share • Dividend declared of 1.8 cents per share fully franked
• Strong orderbook of $408 million over FY2022 of $295 million and FY2023 of $113 million
• FY2022 forecast revenue expected to be circa $400m, with FY2022 EBITDA expected to be in the range of $34-38 million
• 74% FY2022 forecast revenue already in order or expected from recurring work
• Tendered pipeline strong at $610 million together with budgets and opportunities circa $2 billi